Adoption and Deadoption of Medications to Treat Hospitalized Patients With COVID-19.

ABSTRACT:

Objectives

The COVID-19 pandemic was characterized by rapidly evolving evidence regarding the efficacy of different therapies, as well as rapidly evolving health policies in response to that evidence. Data on adoption and deadoption are essential as we learn from this pandemic and prepare for future public health emergencies.

Design

We conducted an observational cohort study in which we determined patterns in the use of multiple medications to treat COVID-19: remdesivir, hydroxychloroquine, IV corticosteroids, tocilizumab, heparin-based anticoagulants, and ivermectin. We analyzed changes both overall and within subgroups of critically ill versus Noncritically ill patients.

Setting

Data from Optum's deidentified Claims-Clinical Dataset, which contains multicenter elect

SUBMITTER: Barbash IJ 

PROVIDER: S-EPMC9333499 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature